Company profile: AmpTec
1.1 - Company Overview
Company description
- Provider of mRNA contract development and manufacturing and RNA technology products, including RNA isolation and mRNA amplification kits, synthetic long RNAs and DNAs, and functional mRNAs, with direct and flexible customer interactions for life science industries and academic research institutions worldwide.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to AmpTec
Aethon
HQ: United States
Website
- Description: Provider of automated hospital delivery and asset management solutions, including TUG®, an automated robotic delivery system transporting scheduled and on-demand deliveries across ancillary, support and patient care units. Offers autonomous mobile robots for material handling in hospitals, manufacturing and hotels, with secured delivery, cart handling, and payloads up to 1,400 lb.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aethon company profile →
Double Rainbow Biosciences
HQ: United States
Website
- Description: Provider of sustainable supply of active pharmaceutical ingredients; access to rare or endangered ingredients for consumer health products; bioengineering solutions for ag tech addressing global food insecurity; PRISM enzyme modification platform to improve specificity and efficacy of medicines via glycosylation; HARMONY molecular biosynthesis platform for sustainable recreation of bioactive compounds; and biosynthetic production of Gastrodin.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Double Rainbow Biosciences company profile →
Caprotec Bioanalytics
HQ: United States
Website
- Description: Provider of proprietary capture protein technology for pharmaceutical, agrochemical, and biotech industries, including Capture Compound Mass Spectrometry (CCMS) based on multifunctional small molecules (Capture Compounds) used to target, capture, and isolate, reducing the complexity of protein mixtures and samples in a targeted and directed manner.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Caprotec Bioanalytics company profile →
PacBio
HQ: United States
Website
- Description: Provider of sequencing systems and technologies for genomic, epigenomic, and transcriptomic analysis, including Revio long-read sequencing, Onso short-read with Sequencing by Binding (SBB) for high accuracy, rare variant detection and difficult-region analysis, Sequel IIe for HiFi reads in whole-genome and RNA sequencing, HiFi sequencing, and Kinnex kits for high-throughput RNA workflows (full-length, single-cell, 16S rRNA).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PacBio company profile →
NanoCellect Biomedical
HQ: United States
Website
- Description: Provider of microfluidic cell analysis and sorting solutions, including WOLF G2 benchtop cell sorter with two lasers and up to nine colors for gentle bulk or single-cell workflows; VERLO image-guided sorter combining flow cytometry with image analysis for complex samples; N1 single-cell dispenser for 96-/384-well plates; CS1 chiller-stirrer for temperature control; and disposable, sterile microfluidic cartridges without cross-contamination.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NanoCellect Biomedical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for AmpTec
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to AmpTec
2.2 - Growth funds investing in similar companies to AmpTec
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for AmpTec
4.2 - Public trading comparable groups for AmpTec
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →